Location: San Francisco, CA
CIK: 0001442756 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value: $1.175B (97.5% shares, 2.5% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 268,023 | $209M | 17.8% | $779.53 | $156.24 | +395.0% | COM | 532457108 |
| THC | TENET HEALTHCARE CORP | 499,243 | $87.87M | 7.5% | $176.00 * | $52.95 | +184.3% | COM NEW | 88033G407 |
| MCK | MCKESSON CORP | 72,313 | $52.99M | 4.5% | $732.78 * | $163.53 | +330.3% | COM | 58155Q103 |
| AXSM | AXSOME THERAPEUTICS INC | 483,105 | $50.43M | 4.3% | $104.39 | $49.35 | +114.6% | COM | 05464T104 |
| ISRG | INTUITIVE SURGICAL INC | 88,967 | $48.35M | 4.1% | $543.41 * | $358.21 | +46.0% | COM NEW | 46120E602 |
| PEN | PENUMBRA INC | 166,261 | $42.67M | 3.6% | $256.63 * | $192.69 | +41.3% | COM | 70975L107 |
| ASND | ASCENDIS PHARMA A/S | 221,754 | $38.27M | 3.3% | $172.60 | $156.94 | — | SPONSORED ADR | 04351P101 |
| SLNO | SOLENO THERAPEUTICS INC | 407,202 | $34.12M | 2.9% | $83.78 * | $50.31 | +48.8% | COM | 834203309 |
| CVS | CVS HEALTH CORP | 479,005 | $33.04M | 2.8% | $68.98 * | $60.15 | +6.7% | COM | 126650100 |
| OM | OUTSET MED INC | 1,664,727 | $31.98M | 2.7% | $19.21 * | $11.92 | +30.9% | COM NEW | 690145206 |
| DHR | DANAHER CORPORATION | 161,413 | $31.89M | 2.7% | $197.54 * | $158.81 | +21.5% | COM | 235851102 |
| EW | EDWARDS LIFESCIENCES CORP | 392,503 | $30.7M | 2.6% | $78.21 * | $74.29 | +0.4% | COM | 28176E108 |
| — | ASCENDIS PHARMA A/S | 23,000,000 | $28.84M | 2.5% | $1.25 | $1.14 | — | NOTE 2.250% 4/0 | 04351PAD3 |
| HCA | HCA HEALTHCARE INC | 72,290 | $27.69M | 2.4% | $383.10 * | $229.48 | +56.3% | COM | 40412C101 |
| HUM | HUMANA INC | 109,511 | $26.77M | 2.3% | $244.48 | $306.16 | -19.4% | COM | 444859102 |
| MOH | MOLINA HEALTHCARE INC | 85,739 | $25.54M | 2.2% | $297.90 * | $238.21 | +31.8% | COM | 60855R100 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 72,220 | $23.55M | 2.0% | $326.09 * | $257.00 | +7.7% | COM | 02043Q107 |
| BBIO | BRIDGEBIO PHARMA INC | 521,793 | $22.53M | 1.9% | $43.18 * | $31.20 | +16.6% | COM | 10806X102 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1,238,846 | $20.76M | 1.8% | $16.76 | $16.76 | — | SPONSORED ADS | 881624209 |
| UNH | UNITEDHEALTH GROUP INC | 65,000 | $20.28M | 1.7% | $311.97 * | $439.75 | -14.7% | Put | 91324P102 |
| — | INDIVIOR PLC | 1,355,931 | $19.99M | 1.7% | $14.74 | $10.28 | — | ORD | G4766E116 |
| NTRA | NATERA INC | 101,250 | $17.11M | 1.5% | $168.94 * | $155.83 | 0.0% | COM | 632307104 |
| COR | CENCORA INC | 53,287 | $15.98M | 1.4% | $299.85 * | $286.82 | 0.0% | COM | 03073E105 |
| MASI | MASIMO CORP | 94,451 | $15.89M | 1.4% | $168.22 * | $159.72 | 0.0% | COM | 574795100 |
| OSCR | OSCAR HEALTH INC | 735,033 | $15.76M | 1.3% | $21.44 * | $11.23 | +32.4% | CL A | 687793109 |
| WAT | WATERS CORP | 43,089 | $15.04M | 1.3% | $349.04 | $332.10 | +3.5% | COM | 941848103 |
| — | AKERO THERAPEUTICS INC | 266,167 | $14.2M | 1.2% | $53.36 | $53.36 | — | COM | 00973Y108 |
| HOLX | HOLOGIC INC | 211,986 | $13.81M | 1.2% | $65.16 * | $59.94 | 0.0% | COM | 436440101 |
| IRTC | IRHYTHM TECHNOLOGIES INC | 88,157 | $13.57M | 1.2% | $153.96 * | $129.23 | 0.0% | COM | 450056106 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 923,375 | $12.95M | 1.1% | $14.02 | $14.02 | 0.0% | COM | 03969K108 |
| ICLR | ICON PLC | 88,181 | $12.83M | 1.1% | $145.45 * | $177.47 | -20.1% | SHS | G4705A100 |
| UNH | UNITEDHEALTH GROUP INC | 34,623 | $10.8M | 0.9% | $311.97 * | $439.75 | -14.7% | COM | 91324P102 |
| SPY | SPDR S&P 500 ETF TR | 17,129 | $10.58M | 0.9% | $617.85 | $617.85 | — | TR UNIT | 78462F103 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 36,391 | $10.46M | 0.9% | $287.35 * | $298.86 | 0.0% | COM | 91307C102 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 178,319 | $9.802M | 0.8% | $54.97 * | $58.89 | 0.0% | COM | 09061G101 |
| — | MERUS N V | 183,882 | $9.672M | 0.8% | $52.60 | $52.60 | — | COM | N5749R100 |
| — | VERONA PHARMA PLC | 80,416 | $7.606M | 0.6% | $94.58 | $94.58 | — | SPONSORED ADS | 925050106 |
| ABBV | ABBVIE INC | 40,782 | $7.57M | 0.6% | $185.62 | $133.14 | +37.2% | COM | 00287Y109 |
| — | BLUEPRINT MEDICINES CORP | 48,444 | $6.21M | 0.5% | $128.18 | $89.00 | — | COM | 09627Y109 |
| NEO | NEOGENOMICS INC | 770,038 | $5.629M | 0.5% | $7.31 * | $11.43 | -29.4% | COM NEW | 64049M209 |
| CMPS | COMPASS PATHWAYS PLC | 1,779,259 | $4.982M | 0.4% | $2.80 | $4.25 | — | SPONSORED ADS | 20451W101 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 732,256 | $4.694M | 0.4% | $6.41 * | $3.56 | +36.7% | COM | 03237H101 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 344,972 | $4.533M | 0.4% | $13.14 | $12.81 | — | SPONSORED ADS | 152309100 |
| ARGX | ARGENX SE | 7,237 | $3.989M | 0.3% | $551.22 | $395.24 | — | SPONSORED ADR | 04016X101 |
| PRAX | PRAXIS PRECISION MEDICINES I | 84,713 | $3.562M | 0.3% | $42.05 * | $29.44 | +29.4% | COM NEW | 74006W207 |
| INBX | INHIBRX BIOSCIENCES INC | 244,261 | $3.486M | 0.3% | $14.27 * | $14.21 | -9.0% | COM | 45720N103 |
| IOBT | IO BIOTECH INC | 1,972,073 | $2.741M | 0.2% | $1.39 * | $2.96 | -61.3% | COM | 449778109 |
| QURE | UNIQURE NV | 174,331 | $2.43M | 0.2% | $13.94 * | $10.89 | +23.5% | SHS | N90064101 |
| RZLT | REZOLUTE INC | 434,134 | $1.936M | 0.2% | $4.46 * | $3.71 | 0.0% | COM NEW | 76200L309 |
| CRBU | CARIBOU BIOSCIENCES INC | 1,358,831 | $1.712M | 0.1% | $1.26 * | $14.05 | -93.0% | COM | 142038108 |
| IRON | DISC MEDICINE INC | 30,799 | $1.631M | 0.1% | $52.96 * | $46.97 | 0.0% | COM | 254604101 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 12,821 | $1.611M | 0.1% | $125.69 * | $114.68 | 0.0% | COM | 64125C109 |
| ERAS | ERASCA INC | 1,072,224 | $1.362M | 0.1% | $1.27 * | $9.44 | -85.8% | COM | 29479A108 |
| GPCR | STRUCTURE THERAPEUTICS INC | 56,594 | $1.174M | 0.1% | $20.74 | $18.29 | — | SPONSORED ADS | 86366E106 |
| VKTX | VIKING THERAPEUTICS INC | 37,729 | $1M | 0.1% | $26.50 | $26.32 | 0.0% | COM | 92686J106 |
| SGMT | SAGIMET BIOSCIENCES INC | 90,000 | $686K | 0.1% | $7.62 * | $12.35 | -65.8% | COM SER A | 786700104 |
| HOWL | WEREWOLF THERAPEUTICS INC | 401,110 | $437K | 0.0% | $1.09 * | $4.07 | -74.7% | COM | 95075A107 |